StockData
Theriva Biologics, Inc. logo

Theriva Biologics, Inc. (TOVX) stock

TOVXNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$0.14+0.00 (+2.86%)

Close on Nov 18, 2026Market cap $6.61MP/E –Yield –

Theriva Biologics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Theriva Biologics's price to book ratio was 0.3× on Jan 31, 2023, against 0.7× a year earlier. Over the last 5 years it ranged from 0.1× to 68.4×, with a median of 3.0×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Jan 31, 20230.3×+0.1
2022Dec 30, 20220.1×−0.4
2021Dec 31, 20210.5×−2.7
2020Apr 30, 20203.2×+1.5
2019Dec 31, 20191.7×−20.1
2017Oct 31, 201721.8×−33.9
2016Oct 31, 201655.7×+47.7
2015Dec 31, 20158.0×−14.7
2014Dec 31, 201422.7×+12.0
2013Dec 31, 201310.7×+2.2
2012Dec 31, 20128.6×+4.3
2011Dec 30, 20114.2×–

More Theriva Biologics figures

See a number that looks wrong?